Saturday 17 October 2026
Export RVP’s income statement to Excel — free account
Retractable Technologies, Inc.
RVP Healthcare Medical Instruments & Supplies
Retractable Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.3 million, up 15.8% from fiscal 2024. In the quarter to June 2026, revenue fell 31.1%, EPS was flat, free cash flow grew 56.7% and total debt fell 32.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.58
0.01
−1.69%
Follow RVP
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 18.75 | 14.95 | 4.20 | 11.47 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
2 | 3 | 4 | 7 | 6 | 6 | 6 | 5 | 4 | 5 |
P/S ratio |
0.95 | 0.63 | 0.59 | 1.17 | 4.35 | 1.25 | 0.60 | 0.74 | 0.63 | 0.60 |
Altman Z-Score |
1.46 | 1.04 | 0.97 | 3.49 | 5.76 | 4.07 | 1.63 | 1.04 | 0.65 | 0.57 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 31.37 | 0.00 | 0.00 | 0.00 | 16.89 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.77 | 2.10 | 1.92 | 3.88 | 4.79 | 6.19 | 4.56 | 4.06 | 3.54 | 2.92 |
P/Operating CF |
33.66 | (24.04) | (25.94) | 68.70 | 35.05 | 16.01 | 4.66 | 17.07 | (18.70) | (38.64) |
Beneish M-Score |
(3.22) | 5.34 | (2.39) | (2.27) | 3.99 | (0.64) | (3.29) | (2.31) | — | (15.44) |
P/B ratio |
1.04 | 0.82 | 0.79 | 1.76 | 7.18 | 2.37 | 0.53 | 0.33 | 0.24 | 0.31 |
Price to Tangible BV |
1.05 | 0.83 | 0.80 | 1.78 | 7.22 | 2.38 | 0.53 | 0.33 | 0.24 | 0.31 |
EV/Sales |
0.54 | 0.30 | 0.30 | 0.91 | 3.94 | 1.00 | 0.07 | (0.31) | (0.69) | (0.34) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 9.92 | 12.95 | 2.55 | 1.87 | 3.39 | 1.68 | 0.97 |
EV/Operating CF |
(20.38) | (3.54) | (8.37) | 17.29 | 16.98 | 5.75 | 0.42 | (4.85) | 1.96 | 1.84 |
EV/FCF |
(5.91) | (3.43) | (6.35) | 24.28 | (157.13) | (7.37) | (112.85) | (7.01) | 1.74 | 1.71 |
Quick Ratio |
2.71 | 2.53 | 2.05 | 2.46 | 2.10 | 2.36 | 5.51 | 6.30 | 6.07 | 4.71 |
Current Ratio |
3.72 | 3.37 | 3.00 | 3.44 | 2.49 | 2.96 | 7.32 | 8.28 | 8.34 | 6.57 |
Net Debt/EBITDA |
4.66 | 3.87 | 21.66 | (2.89) | (1.35) | (0.63) | (13.22) | 11.55 | 3.20 | 2.69 |
Debt/Assets |
10.13% | 9.15% | 8.24% | 6.74% | 3.56% | 1.02% | 0.93% | 0.86% | 0.77% | 0.63% |
Debt/Equity |
0.14 | 0.13 | 0.12 | 0.09 | 0.08 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
Asset Turnover |
0.74 | 0.90 | 0.89 | 1.10 | 1.14 | 1.21 | 0.47 | 0.23 | 0.19 | 0.25 |
Operating CF/Net income |
0.18 | 0.66 | 0.58 | 0.90 | 0.71 | 0.59 | 3.46 | (0.38) | 0.95 | 0.55 |
Capex/Depreciation |
(2.23) | (0.11) | (0.43) | (0.74) | (25.30) | (46.42) | (3.66) | (0.11) | (0.19) | (0.07) |
Interest Coverage |
(16.44) | (17.92) | (7.50) | 17.81 | 92.47 | 319.52 | (5.00) | (75.48) | (172.29) | (240.90) |
| (15.35%) | (16.53%) | (7.98%) | 9.30% | 68.81% | 75.15% | 4.72% | (7.05%) | (13.03%) | (15.89%) | |
| (10.85%) | (11.54%) | (5.45%) | 6.42% | 36.94% | 35.87% | 2.41% | (3.86%) | (7.12%) | (8.44%) | |
ROIC |
(13.84%) | (14.96%) | (5.18%) | 10.63% | 92.90% | 85.74% | (0.94%) | (13.41%) | (30.09%) | (34.56%) |
Return on Tangible Assets |
(13.93%) | (14.77%) | (7.29%) | 7.94% | 36.78% | 35.53% | 2.74% | (4.48%) | (7.98%) | (9.65%) |
Average Days of Receivables |
39.99 | 54.03 | 54.99 | 57.76 | 94.22 | 67.54 | 59.49 | 99.02 | 96.81 | 78.33 |
Research and Development Expense of Revenue |
1.92% | 2.15% | 1.87% | 1.23% | 0.70% | 0.48% | 0.55% | 1.33% | 2.04% | 1.77% |
Selling, General and Administrative Expense of Revenue |
42.99% | 37.72% | 33.63% | 25.48% | 15.10% | 11.60% | 30.14% | 45.91% | 58.71% | 51.20% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1.30% | 1.95% | 0.00% | 0.00% | 0.00% | 1.94% | 10.68% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.56 | 0.72 | 0.74 | 0.36 | 0.04 | (0.01) | (0.01) | (0.08) | (0.01) | (0.22) |
Graham Number |
0.00 | 0.00 | 0.00 | 1.24 | 4.92 | 10.41 | 3.30 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(15.46%) | (20.59%) | (10.00%) | 5.33% | 6.69% | 23.81% | 8.72% | (22.22%) | (59.42%) | (54.55%) |
Free Cash Flow Yield |
(9.63%) | (13.87%) | (8.05%) | 3.19% | (0.58%) | (10.89%) | (0.11%) | 5.92% | (62.92%) | (32.97%) |
Revenue per Share |
1.02 | 1.08 | 1.02 | 1.28 | 2.47 | 5.56 | 2.88 | 1.46 | 1.10 | 1.28 |
Operating CF per Share |
(0.03) | (0.09) | (0.04) | 0.07 | 0.57 | 0.97 | 0.51 | 0.09 | (0.39) | (0.24) |
Capex per Share |
(0.07) | 0.00 | (0.01) | (0.02) | (0.63) | (1.72) | (0.51) | (0.03) | (0.05) | (0.02) |
Free Cash Flow per Share |
(0.09) | (0.09) | (0.05) | 0.05 | (0.06) | (0.75) | 0.00 | 0.06 | (0.43) | (0.25) |
Cash per Share |
0.55 | 0.47 | 0.39 | 0.42 | 1.13 | 1.43 | 1.56 | 1.58 | 1.49 | 1.24 |
Shareholders Equity per Share |
0.96 | 0.85 | 0.78 | 0.87 | 1.50 | 2.93 | 3.24 | 3.32 | 2.91 | 2.48 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.96 | 0.85 | 0.78 | 0.87 | 1.50 | 2.93 | 3.24 | 3.32 | 2.91 | 2.48 |
Free Cash Flow |
(2.74) | (3.01) | (1.58) | 1.56 | (2.05) | (25.57) | (0.06) | 1.91 | (13.00) | (7.60) |
Working Capital |
19.50 | 18.71 | 17.22 | 20.15 | 41.58 | 69.18 | 76.67 | 68.27 | 64.49 | 53.49 |
Capital Expenditures |
(1.95) | (0.09) | (0.38) | (0.63) | (21.05) | (58.37) | (16.83) | (0.85) | (1.44) | (0.54) |
Net Current Asset Value |
16.01 | 15.63 | 14.50 | 17.77 | 14.39 | (2.63) | (0.32) | (2.73) | (0.28) | (5.17) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 12.77 | 13.40 | 2.60 | 0.00 | 1.17 | 1.07 | 0.62 |
Capex to Sales |
0.07 | 0.00 | 0.01 | 0.02 | 0.26 | 0.31 | 0.18 | 0.02 | 0.04 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 16.49 | 14.80 | 3.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.07 | 0.07 | 0.08 | 0.08 | 0.03 | 0.01 | 0.05 | 0.08 | 0.09 | 0.10 |
Cash ROIC |
(5.68%) | (6.62%) | (3.82%) | 3.48% | (2.25%) | (17.09%) | (0.04%) | 1.29% | (9.77%) | (6.77%) |
Accounts Receivable Turnover |
7.30 | 8.24 | 6.58 | 7.19 | 5.90 | 6.73 | 3.77 | 3.20 | 3.21 | 4.51 |
Accounts Payable Turnover |
3.83 | 5.20 | 4.46 | 5.33 | 4.22 | 5.08 | 4.97 | 6.17 | 7.51 | 7.94 |
Inventory Turnover |
2.93 | 3.71 | 3.35 | 3.69 | 5.07 | 6.04 | 3.23 | 1.80 | 1.85 | 2.10 |
Average Days of Payables |
83.77 | 73.79 | 85.02 | 66.08 | 132.29 | 80.06 | 35.12 | 50.58 | 45.96 | 51.00 |
Days of Inventory on Hand |
131.45 | 92.38 | 119.46 | 98.32 | 83.28 | 80.78 | 113.42 | 186.06 | 205.54 | 164.15 |
Average Receivables |
4.08 | 4.19 | 5.06 | 5.81 | 13.87 | 28.00 | 25.16 | 13.64 | 10.30 | 8.49 |
Average Payables |
5.08 | 4.71 | 5.16 | 5.19 | 10.63 | 18.33 | 13.40 | 5.59 | 4.53 | 4.82 |
Average Inventory |
6.66 | 6.61 | 6.88 | 7.50 | 8.84 | 15.41 | 20.64 | 19.13 | 18.39 | 18.19 |
Average Assets |
40.54 | 38.47 | 37.56 | 38.07 | 72.07 | 155.64 | 200.99 | 187.67 | 170.20 | 151.68 |
Average Common Equity |
28.66 | 26.86 | 25.61 | 26.30 | 38.69 | 74.28 | 102.62 | 102.68 | 93.00 | 80.54 |
Columns are period end dates